Home Reimbursed medicines
List of reimbursed medicines and maximum prices 2026
The national CANAMED catalogue sets the maximum retail price for every medicine authorised in Romania, and CNAS reimburses part of the cost through the reimbursement sublists (A 90%, B 50%, C1/C2 100%, D 20%). On this page you will find 33,613 CANAMED entries organised by 1,653 active substances (INN) — with the maximum price, prescription status and, where available, the reimbursement percentage.
In short: the CANAMED catalogue contains 33,613 medicines authorised in Romania, covering 1,653 active substances (INN) from 1,366 manufacturers. The maximum retail price is approved by the Ministry of Health and no pharmacy may sell above it. Reimbursement works through the CNAS sublists — A 90%, B 50%, C1 and C2 100%, D 20% — and the percentage applies to the reference price of the therapeutic group, not to the shelf price: that is why you may pay a difference even for a “100% reimbursed” medicine. For 4,194 of the catalogue entries we also have the reimbursement percentage on record. Data re-imported regularly — latest import: 2026-11-03.
Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.
How it works
Romania's reimbursement system, explained for everyone
In Romania, a medicine's path to the pharmacy shelf goes through three institutions. ANMDMR (the National Agency for Medicines and Medical Devices) authorises the medicine and enters it in the nomenclature. The Ministry of Health approves the maximum manufacturer price and the maximum retail price, published in the national CANAMED catalogue — the legal cap above which no pharmacy may sell. CNAS (the National Health Insurance House) then decides whether, and how much of, the cost is reimbursed for insured patients, by placing the medicine on one of the reimbursement sublists.
This is where the most common confusion arises: the reimbursement percentage does not apply to the shelf price, but to the reference price of the therapeutic group — usually calculated from the cheapest medicine with the same active substance (INN), strength and pharmaceutical form. If the prescribed medicine costs exactly the reference price, you pay only the unreimbursed part. If you choose a more expensive product (often the original instead of the generic), you also pay the difference up to its selling price. In practice, “100% reimbursed” means free only if you stick to the reference product.
What you can do as a patient: ask the doctor whether they can prescribe by INN (the active substance) instead of brand, ask the pharmacist for the generic option from the same group and compare shelf prices across chains before you go — differences for the same product often reach 20–40%. That is what the HartaFarmacii price comparator is for, and on each medicine's page we also show the CANAMED maximum price, so you can see at once how close to the cap each pharmacy sells. For an overview by category, see the Medicine Price Barometer: median price differences by category.
The table below aggregates the CANAMED catalogue by active substance: for each INN you can see how many medicines (brands, strengths, forms) the catalogue holds and the average maximum price. The dedicated page for each INN lists every entry — brand name, manufacturer, maximum price, prescription status and reimbursement percentage where recorded — plus links to live pharmacy prices. The list is updated along with CANAMED, so it is worth bookmarking: maximum prices and sublist placements change several times a year.
The CNAS sublists
Reimbursement percentages by sublist
-
Sublist A 90%
CNAS reimburses 90% of the product's reference price for any insured person with a reimbursed prescription (e.g. indapamide, sertraline). The patient pays the rest, plus the difference up to the price of the chosen product.
-
Sublist B 50%
CNAS reimburses 50% of the reference price (e.g. atorvastatin). The patient pays the rest plus, where there is one, the difference up to the selling price of the chosen product. Low-income pensioners receive 90%.
-
Sublist C1 100%
100% reimbursement of the reference price for the chronic diseases on the C1 sublist, with the diagnosis written on the prescription (e.g. levothyroxine). The same product may be on A or B for other patients.
-
Sublist C2 100%
Medicines from the national health programmes (e.g. diabetes — metformin —, oncology, rare diseases), 100% of the reference price, on a prescription from the programme doctor.
-
Sublist D 20%
CNAS reimburses 20% of the reference price; the patient pays the rest.
The percentage applies to the reference price set by CNAS, not to the selling price. Sublist placement is regulated by Government Decision 720/2008, updated periodically — always check the current situation with the doctor or pharmacist.
The catalogue by active substance
Top INNs in CANAMED
The active substances with the most medicines in the catalogue — open the INN's page for the full list with maximum prices.
Full catalogue
Full alphabetical index of active substances
The table above shows only the top 100 — here are all the active substances with at least 2 CANAMED entries.
See all 1,091 active substances (A–Z)
Frequently asked questions
FAQ · reimbursed medicines
-
What does a 90% reimbursed medicine mean?
It means the medicine is on sublist A: the insurance house (CNAS) reimburses 90% of the reference price of its therapeutic group — not of the shelf price of the product you choose. If you choose a product more expensive than the reference price (usually an original instead of a generic), you pay the difference. That is why, for the same active substance (INN), the cheapest generic can mean an out-of-pocket cost close to zero. -
Who sets the maximum prices of medicines in Romania?
Maximum retail prices are approved by the Ministry of Health and published in the national CANAMED catalogue. The authorisation of medicines and the nomenclature belong to ANMDMR (the National Agency for Medicines and Medical Devices of Romania), while the reimbursement lists and reference prices are managed by CNAS. No pharmacy may legally sell above the CANAMED maximum price. -
What are reimbursement sublists A, B, C and D?
Sublist A — 90% (common chronic diseases), Sublist B — 50% (partial reimbursement), Sublist C1 — 100% (serious chronic diseases), Sublist C2 — 100% (national health programmes: oncology, diabetes, rare diseases), Sublist D — 20%. The percentage always applies to the reference price set by CNAS, not to the selling price. Sublist placement is set by government decision (Government Decision 720/2008, updated periodically). -
Why do I pay a difference even for a 100% reimbursed medicine?
Because “100%” refers to the group's reference price, usually calculated from the cheapest medicine in that group. If the doctor prescribes (or you choose) a product with a selling price above the reference, you pay the difference. Solutions: ask the pharmacist for the generic option from the same group or compare prices across pharmacies with the HartaFarmacii comparator. -
How do I find out whether my medicine is reimbursed and how much I pay?
The surest way: ask the prescribing doctor or the pharmacist — the electronic prescription automatically shows the sublist and your contribution. As a guide, you can look the medicine up on HartaFarmacii: on each product's page we show the CANAMED maximum price (where available) and the shelf prices at the large chains, so you can see the real difference before you reach the pharmacy. -
How often are CANAMED and the reimbursement list updated?
CANAMED is updated periodically by order of the Minister of Health (usually several times a year), and the reimbursement lists by government decisions amending Government Decision 720/2008. The HartaFarmacii database holds 33,613 CANAMED entries, covering 1,653 active substances (INN). Latest import into the HartaFarmacii database: 2026-11-03. For 4,194 of the catalogue entries we also have the reimbursement percentage on record. -
Is the CANAMED maximum price the price I pay at the pharmacy?
Not necessarily — it is the legal cap, not the actual price. Pharmacies may sell below the maximum price, and the differences between chains (Catena, Dr. Max, Tei, Dona) can be significant for the same product. For OTC medicines and supplements the differences often reach 20–40%. Check live prices with our comparator before you go.
Official sources
Where the data come from
- CANAMED — the national medicine price catalogue — maximum retail price per authorised medicine.
- ANMDMR — authorisation of medicines and the official nomenclature (CIM codes, INN, prescription status).
- CNAS — the reimbursement sublists and reference prices (Government Decision 720/2008, updated periodically).
- Ministry of Health — approval of maximum prices by ministerial order.
Before you go